StockData
Precigen, Inc. logo

Precigen, Inc. (PGEN) stock

PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$4.29−0.01 (-0.23%)

Close on Nov 17, 2026Market cap $1.54BP/E –Yield –

Earnings

Precigen's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 24, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q3 FY2026
$74.10M
EPS, Q3 FY2026
$0.08
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Precigen's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 24, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 5, 2026after the close$74.10M–$0.08Release
Q2 FY2026ended Jun 30, 2026Aug 4, 2026during market hours$55.00M–$0.05Release
Q1 FY2026ended Mar 31, 2026May 13, 2026during market hours$23.25M–-$0.02Release
Q4 FY2025ended Dec 31, 2025Mar 25, 2026during market hours–––Release
Q3 FY2025ended Sep 30, 2025Nov 13, 2025during market hours–––Release
Q1 FY2025ended Mar 31, 2025May 14, 2025during market hours–––Release
Q4 FY2024ended Dec 31, 2024Mar 19, 2025during market hours–––Release
Q3 FY2024ended Sep 30, 2024Nov 14, 2024during market hours$953.00K-30.9%-$0.09Release
Q2 FY2024ended Jun 30, 2024Aug 14, 2024during market hours$717.00K-59.4%-$0.23Release
Q1 FY2024ended Mar 31, 2024May 14, 2024during market hours$1.07M-42.5%-$0.10Release
Q4 FY2023ended Dec 31, 2023Mar 19, 2024during market hours–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Precigen has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Precigen puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Precigen filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. Results
  6. Update
  7. Update
  8. Results
  9. Results
  10. Update
  11. Update
  12. Results
  13. Results
  14. Results
  15. Results

See a number that looks wrong?